StockDriftsStockDriftsTop 8 Versant Venture Management, LLC Holdings
| Stock | Company | % Port. | Shares | Value | Activity | Ownership | Avg. Cost | Date |
|---|---|---|---|---|---|---|---|---|
| GLUE | Monte Rosa Therapeutics, Inc. | 37% | 3.18M | $52.3M | -27.42%(-1.20M) | $6.12(+209.80%) | 2026-03-31 | |
| IPSC | Century Therapeutics, Inc. | 19.44% | 12.17M | $27.5M | new | $1.63(+40.09%) | 2026-03-31 | |
| LENZ | Lenz Therapeutics, Inc. | 17.19% | 2.66M | $24.3M | +0.00%(+0) | $37.95(-78.79%) | 2026-03-31 | |
| JBIO | Jade Biosciences, Inc. | 15.16% | 1.53M | $21.4M | +0.00%(+0) | $49.27(-49.12%) | 2026-03-31 | |
| CTNM | Contineum Therapeutics, Inc. | 5.01% | 542.6K | $7.1M | +0.00%(+0) | $17.61(-19.65%) | 2026-03-31 | |
| CRSP | CRISPR Therapeutics AG | 5.01% | 148.8K | $7.1M | +0.00%(+0) | $44205.20(-99.88%) | 2026-03-31 | |
| SKYE | Skye Bioscience, Inc. | 0.87% | 2.01M | $1.2M | +0.00%(+0) | $9.18(-91.07%) | 2026-03-31 | |
| TPST | Tempest Therapeutics, Inc. | 0.31% | 269.8K | $442K | +0.00%(+0) | $14.53(-87.33%) | 2026-03-31 |
| Performance Metric | 3-Year Annualized | 3-Year Cumulative |
|---|---|---|
| Top 20 Holdings Weighted | -5.22% | -14.85% |
| Top 20 Holdings Unweighted | -7.76% | -21.52% |
Sign up free to track Versant Venture Management, LLC, compare funds side by side, and get alerts the moment positions change.